Ashram Online (526187)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹6.29 |
| Market Cap | ₹7.96 Cr |
| P/E Ratio | 0 |
| ROCE | -0.32% |
| ROE | -1.11% |
| Dividend Yield | 0% |
| Profit Growth | -150% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹4.03 — ₹6.29 |
| Sector | Healthcare Services |
| Book Value | ₹12.15 |
Strengths
- Trades at 0.52 times book value, offering a potential margin of safety on net assets.
- Price of ₹6.29 is near the 52-week high of ₹6.48, showing recent market interest.
- Healthcare service provider sector may have strategic value or assets worth unlocking.
- No dividend obligation, preserving cash for potential operational revival.
Concerns
- Zero sales and zero net profit in the latest quarter indicate a dormant business.
- Profit growth of -150% and negative ROE/ROCE show persistent value destruction.
- Piotroski F-Score of 2/9 signals severe financial distress or weak operational health.
- Missing promoter holding and debt/equity data reduce transparency and assessability.
AI Analysis
When I look at Ashram Online, I see a business that fails the first test of investing: it earns nothing. Sales are zero, net profit is zero, and profit growth has collapsed by 150%. A company that cannot generate revenue is not a business; it is a shell. As Graham would say, price is what you pay, value is what you get. Here, the balance sheet offers some solace. The stock trades at ₹6.29 against a book value of ₹12.15, a price-to-book of 0.52. That implies the market is giving you roughly 48 paise for every rupee of net assets. But cheap can become cheaper if the asset base erodes. Return on equity is -1.11%, and ROCE is -0.32% — the company is destroying value, not creating it. The Piotroski F-Score of 2/9 confirms severe financial weakness. There is no debt-to-equity data, so I cannot judge leverage, but I notice no dividend and no promoter holding disclosure. This is not a compounder, not a stalwart, and not a turnaround until sales actually appear. It is a classic asset play, trading below book, but with zero operating pulse. If management can unlock the underlying healthcare assets or generate any revenue, there is upside. But as a value investor, I demand a margin of safety not just in book value, but in earning power. Ashram Online has neither earnings nor momentum. I would keep it on a watchlist, not in a portfolio. Only a meaningful improvement in operations or a clear catalyst would justify owning it.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer